Affinivax

Developer of technology-based conjugate vaccines against infectious diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2013 groups132 employees language affinivax.com

Registered entities

Innovation

7 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 2,261 times.

YearFilings
20181
20191
20202
20211
20222
20234
20244
20253
20264

Investor mix

16 investors on record; lead investors include Gates, Viking Global Investors, Rock Springs Capital, Foresite Capital; 2 have since exited.

Investor typeCountShare
Venture capital319%
Private equity319%
Bank & private debt16%
Other / undisclosed956%
Coming soon